We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 38

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Ban on embryonic stem cell patenting in Europe Court of Justice rules on meaning of "human embryo" in stem cells debate

  • Hogan Lovells
  • -
  • European Union, Germany
  • -
  • October 25 2011

The Court of Justice of the European Union (CJEU) handed down its long-awaited judgment in the Brüstle case on the patentability of stem cell inventions

German Supreme Court finally finds patent on embryonic stem cell technology valid under reasonable terms while the position of the EPO is still open

  • Prüfer & Partner GbR
  • -
  • European Union, Germany
  • -
  • February 1 2013

Following the preliminary ruling of the Court of Justice of the European Union (CJEU; case C-3410), the long awaited final decision of the German

Gifts and favours to doctors are not a criminal offence

  • CMS Hasche Sigle
  • -
  • Germany
  • -
  • August 28 2012

The Federal Court of Justice has ruled that it is not a criminal offence for German doctors who have their own practice and are authorised to treat patients insured with a statutory healthcare fund to accept favours or gifts from pharmaceutical companies in return for prescribing particular drugs and medication

AG opinion on medical devices qualification issues for e-health software products

  • CMS Cameron McKenna
  • -
  • European Union, Germany
  • -
  • May 21 2012

On 15 May 2012, the Advocate General published his Opinion in the European Court of Justice reference in Brain Products GmbH v BioSemi VOF and Others by the German Supreme Court (Bundesgerichtshof

FSC decides on patentability of neural progenitor cells II (Brustle)

  • Bird & Bird
  • -
  • Germany
  • -
  • February 25 2013

Recently, the German Federal Supreme Court decided on a nullity action on the patentability of progenitor cells extracted from human embryonic stem

Federal Supreme Court of Germany decides on second medical use claims that relate to dosage recommendations

  • Bird & Bird
  • -
  • Germany
  • -
  • May 29 2007

In the decision Carvedilol II (file X ZR 23601), the Federal Supreme Court had to deal with the validity of the German part of a European patent that was defended with a main claim, the essential part of which reads as follows: “Use of Carvedilol for the manufacture of a medicament , wherein the medicament is administered in an initial dose of 3.125 mg , daily for a period of 7- 28 days .”

End of German Olanzapine battle: Federal Supreme Court upholds patent

  • Bird & Bird
  • -
  • Germany
  • -
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance

ECJ: no pharmacy chains in Germany

  • Bird & Bird
  • -
  • European Union, Germany
  • -
  • July 17 2009

On 19 May 2009 the European Court of Justice (ECJ) has confirmed that Germany can have national legislation which prevents non-pharmacists from owning and operating pharmacies (joined cases C-17107 and C- 172-07

The German Plavix case: loopholes in European data protection?

  • Jones Day
  • -
  • Germany
  • -
  • September 1 2008

Originators beware: the marketing authorization granted by the German authority for a generic formulation of Plavix, and the subsequent decision of the competent court in preliminary proceedings to allow the marketing of the drug, raises questions about the protection of data under the European regulatory framework

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy